1. Home
  2. RNW vs LGND Comparison

RNW vs LGND Comparison

Compare RNW & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNW
  • LGND
  • Stock Information
  • Founded
  • RNW 2011
  • LGND 1987
  • Country
  • RNW United Kingdom
  • LGND United States
  • Employees
  • RNW N/A
  • LGND N/A
  • Industry
  • RNW Electric Utilities: Central
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • RNW Utilities
  • LGND Health Care
  • Exchange
  • RNW Nasdaq
  • LGND Nasdaq
  • Market Cap
  • RNW 2.2B
  • LGND 2.0B
  • IPO Year
  • RNW N/A
  • LGND 1992
  • Fundamental
  • Price
  • RNW $6.21
  • LGND $104.97
  • Analyst Decision
  • RNW Strong Buy
  • LGND Strong Buy
  • Analyst Count
  • RNW 1
  • LGND 7
  • Target Price
  • RNW $7.50
  • LGND $144.67
  • AVG Volume (30 Days)
  • RNW 915.5K
  • LGND 127.9K
  • Earning Date
  • RNW 06-04-2025
  • LGND 05-06-2025
  • Dividend Yield
  • RNW N/A
  • LGND N/A
  • EPS Growth
  • RNW N/A
  • LGND N/A
  • EPS
  • RNW 0.04
  • LGND N/A
  • Revenue
  • RNW $1,006,524,942.00
  • LGND $167,133,000.00
  • Revenue This Year
  • RNW N/A
  • LGND $16.47
  • Revenue Next Year
  • RNW $38.75
  • LGND $19.44
  • P/E Ratio
  • RNW $158.29
  • LGND N/A
  • Revenue Growth
  • RNW N/A
  • LGND 27.28
  • 52 Week Low
  • RNW $5.15
  • LGND $67.72
  • 52 Week High
  • RNW $7.49
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • RNW 55.37
  • LGND 47.85
  • Support Level
  • RNW $6.03
  • LGND $100.30
  • Resistance Level
  • RNW $6.23
  • LGND $107.62
  • Average True Range (ATR)
  • RNW 0.25
  • LGND 6.00
  • MACD
  • RNW 0.05
  • LGND 0.59
  • Stochastic Oscillator
  • RNW 96.95
  • LGND 74.98

About RNW ReNew Energy Global plc

ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: